Financial Results for Quarter & Nine Months period ended 31st December 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Yash Chemex reported Q3 FY26 standalone revenue from operations of Rs. 1,901.08 lakhs, down from Rs. 2,255.96 lakhs in the previous quarter but up about 14% year-on-year. For the nine-month period, standalone revenue rose nearly 48% to Rs. 5,931.67 lakhs versus Rs. 4,012.36 lakhs last year, while standalone net profit was almost flat at Rs. 127.74 lakhs vs Rs. 127.99 lakhs. On a consolidated basis (including subsidiary Yasons Chemex Care Limited), nine-month revenue jumped around 58% to Rs. 10,305.44 lakhs and net profit grew about 22% to Rs. 291.52 lakhs, with consolidated EPS at Rs. 2.07. Statutory auditor M/s S. L. Patel & Co. issued an unmodified limited review opinion on both sets of results. The Board also appointed two new Independent Directors (Mr. Dhanik Mehta and Mr. Bhaveshkumar Shah), reconstituted board committees, and approved a postal ballot notice for shareholder approval.
Strong top-line growth driven by the subsidiary is a positive signal, but standalone profitability has stagnated, indicating margin pressure at the parent level. The director appointments and committee restructuring strengthen governance, while the clean audit opinion offers comfort; no immediate negative catalyst for the stock.